Covalent binding of 15-deoxy-delta12,14-prostaglandin J 2 to PPARγ

Biochemical and Biophysical Research Communications

Volumn 337, Issue 2, 2005, Pages 521-525

  Soares, A F ^a   Nosjean, O ^b   Cozzone, D ^a   D'Orazio, D ^c   Becchi, M ^d   Guichardant, M ^a   Ferry, G ^b   Boutin, J A ^b   Lagarde, M ^a   Geloen A ^a  

^a Univ Lyon   (France)

^b INSTITUT DE RECHERCHES SERVIER   (France)

^c DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

^d INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

Author keywords

15 deoxy delta12,14 prostaglandin J2; Covalent binding; Mass spectrometry; Peroxisome proliferator activated receptor gamma (PPAR )

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE;

ARTICLE; CHEMICAL REACTION; COVALENT BOND; INCUBATION TIME; LIGAND BINDING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; TRYPSINOLYSIS;

ADIPOCYTES; HYPOGLYCEMIC AGENTS; LIGANDS; PPAR GAMMA; PROSTAGLANDIN D2; PROTEIN BINDING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; THIAZOLIDINEDIONES; TIME FACTORS;

EID: 26444464734     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.09.085     Document Type: Article

References (25)

1. N.S. Tan, L. Michalik, B. Desvergne, and W. Wahli Multiple expression control mechanisms of peroxisome proliferator-activated receptors and their target genes J. Steroid Biochem. Mol. Biol. 93 2005 99 105
2. 2 is a ligand for the adipocyte determination factor PPAR gamma Cell 83 1995 803 812
3. 2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation Cell 83 1995 813 819
4. I.R. Jowsey, P.R. Murdock, G.B. Moore, G.J. Murphy, S.A. Smith, and J.D. Hayes Prostaglandin D2 synthase enzymes and PPARgamma are co-expressed in mouse 3T3-L1 adipocytes and human tissues Prostaglandin Other Lipid Mediat. 70 2003 267 284
5. L.C. Bell-Parikh, T. Ide, J.A. Lawson, P. McNamara, M. Reilly, and G.A. FitzGerald Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma J. Clin. Invest. 112 2003 945 955
6. O. Nosjean, and J.A. Boutin Natural ligands of PPARgamma: are prostaglandin J(2) derivatives really playing the part? Cell. Signal. 14 2002 573 583
7. S. Cuzzocrea, B. Pisano, L. Dugo, A. Ianaro, N.S. Patel, R.D. Paola, T. Genovese, P.K. Chatterjee, M.D. Rosa, A.P. Caputi, and C. Thiemermann Rosiglitazone and 15-deoxy(delta)12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-(gamma) (PPAR-(gamma)), reduce ischemia/reperfusion injury of the gut Br. J. Pharmacol. 140 2003 366 376
8. T.M. Collin, and C. Thiemermann The PPARgamma ligand 15-deoxy(delta)12, 14-prostaglandin J(2) reduces the liver injury in endotoxic shock Eur. J. Pharmacol. 476 2003 257 258
9. N. Kanai, R. Lu, J.A. Satriano, Y. Bao, A.W. Wolkoff, and V.L. Schuster Identification and characterization of a prostaglandin transporter Science 268 1995 866 869
10. Y. Bao, M.L. Pucci, B.S. Chan, R. Lu, S. Ito, and V.L. Schuster Prostaglandin transporter PGT is expressed in cell types that synthetize and release prostanoids Am. J. Physiol. Renal Physiol. 282 2002 F1103 F1110
11. D.S. Straus, G. Pascual, M. Lei, J.S. Welch, M. Ricote, C.H. Hsiang, L.L. Sengchanthalangsy, G. Ghosh, and C.K. Glass 15-deoxy-delta12,14prostaglandin J2 inhibits multiple steps in the NK-κ B signaling pathway Proc. Natl. Acad. Sci. USA 97 2000 4844 4849
12. J.M. Oliva, D. Pérez-Sala, A. Castrillo, N. Martinez, F.J. Canada, L. Bosca, and J.M. Rojas The cyclopentenone 15-desoxy-delta12,14-prostagladin J2 binds to and activates H-Ras Proc. Natl. Acad. Sci. USA 100 2003 4772 4777
13. T. Shibata, T. Yamada, T. Ishii, S. Kumazawa, H. Nakamura, H. Masutani, and K. Uchida Thioredoxin as a molecular target of cyclenpentenone prostaglandins J. Biol. Chem. 278 2003 26046 26054
14. C. Thévenon, M. Guichardant, and M. Lagarde Gas chromatography-mass spectrometry measurement of 15-deoxy-delta12,14-PGJ2, the peroxisome proliferator-activated receptor gamma ligand, in urine Clin. Chem. 47 2001 768 770
15. Z.C. Dang, V. Audinot, S.E. Papapoulos, J.A. Boutin, and C.W. Lowik Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein J. Biol. Chem. 278 2003 962 967
16. G. Ferry, V. Bruneau, P. Beauverger, M. Goussard, M. Rodriguez, V. Lamamy, S. Dromaint, E. Canet, J.P. Galizzi, and J.A. Boutin Binding of prostaglandins to human PPARg: tool assessment and new natural ligands Eur. J. Pharmacol. 417 2001 77 89
17. T. Shibata, T. Yamada, T. Ishii, S. Kumazawa, H. Nakamura, H. Masutani, J. Yodoi, and K. Uchida Thioredoxin as a molecular target of cyclopentenone prostaglandins J. Biol. Chem. 278 2003 26046 26054
18. A. Rossi, P. Kapahi, G. Natoli, T. Takahashi, Y. Chen, M. Karin, and M.G. Santoro Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase Nature 403 2000 108 130
19. E. Cernuda-Morollon, E. Pineda-Molina, F.J. Canada, and D. Perez-Sala 15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit J. Biol. Chem. 276 2001 35530 35536
20. P.J. Moos, K. Edes, P. Cassidy, P. Massuda, and F.A. Fitzpatrick Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase J. Biol. Chem. 278 2003 745 750
21. D. Perez-Sala, E. Cernuda-Morollon, and F.J. Canada Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-Delta 12,14-prostaglandin J2 J. Biol. Chem. 278 2003 51251 51260
22. R.C. Murphy, and S. Zarini Glutathione adducts of oxyeicosanoids Prostaglandins Other Lipid Mediat. 2002 68 69
23. H.S. Camp, O. Lio, S.C. Wise, Y.H. Hong, C.L. Frankowski, X. Shen, R. Vanbogelen, and T. Leff Differential activation of peroxisome proliferator-activated receptor-γ by troglitazone and rosiglitazone Diabetes 49 2000 539 547
24. J.M. Olefsky Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists J. Clin. Invest. 106 2000 467 472
25. G. Pascual, A.L. Fong, S. Ogawa, A. Gamliel, A.C. Li, V. Perissi, D.W. Rose, T.M. Willson, M.G. Rosenfeld, C.K. Glass, A SUMOy-lation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma, Nature (2005). doi: 10.1038/nature 03988.